Healthcare consumers may be the driving force behind Health 2.0, but are they really in control? And who knows what the final destination will be?
By Bradley Schmidt
Advertisement
Articles by By Bradley Schmidt
Advertisement
Latest Updated Articles
- Where Do We Go from Here? A Health 2.0 Progress Report
Published: January 19th 2009 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
FDA Approves Daratumumab and Hyaluronidase Plus VRd for Newly Diagnosed Multiple Myeloma
2
PD-L1 Expression Is More Predictive of Response to Pembrolizumab on Metastatic Sites in High-Grade Serous Ovarian Cancer
3
Ixazomib-Containing Combinations Signal Potential for More PI-Based Regimens in R/R Multiple Myeloma
4
Dr Braunstein on the FDA Approval of Subcutaneous Daratumumab With VRd For Newly Diagnosed Multiple Myeloma
5